Rhythm Pharmaceuticals Files 8-K on Shareholder Votes & Financials
Ticker: RYTM · Form: 8-K · Filed: Jun 26, 2025 · CIK: 1649904
| Field | Detail |
|---|---|
| Company | Rhythm Pharmaceuticals, Inc. (RYTM) |
| Form Type | 8-K |
| Filed Date | Jun 26, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, financial-reporting, bylaws
Related Tickers: RYTM
TL;DR
RHYTHM PHARMACEUTICALS (RYTM) filed an 8-K covering shareholder votes, bylaws, and financials. Stay tuned for details.
AI Summary
Rhythm Pharmaceuticals, Inc. filed an 8-K on June 24, 2025, reporting on matters submitted to a vote of security holders and financial statements. The filing also includes amendments to its articles of incorporation or bylaws and a change in its fiscal year. The company is incorporated in Delaware and its principal executive offices are located in Boston, MA.
Why It Matters
This 8-K filing provides updates on corporate governance and financial reporting for Rhythm Pharmaceuticals, which is crucial for investors to understand the company's operational and strategic direction.
Risk Assessment
Risk Level: low — This filing is routine and primarily procedural, reporting on corporate actions and financial statements without indicating significant new risks.
Key Players & Entities
- RHYTHM PHARMACEUTICALS, INC. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- 222 Berkeley Street 12th Floor Boston, MA 02116 (address) — Principal executive offices
- June 24, 2025 (date) — Date of earliest event reported
FAQ
What specific matters were submitted to a vote of security holders?
The filing indicates that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in the excerpt.
Are there any changes to Rhythm Pharmaceuticals' bylaws or articles of incorporation?
Yes, the filing explicitly states 'Amendments to Articles of Incorporation or Bylaws' as an item of information.
When is Rhythm Pharmaceuticals' fiscal year end?
The fiscal year end for Rhythm Pharmaceuticals is December 31 (1231).
What is the SEC file number for Rhythm Pharmaceuticals?
The SEC file number for Rhythm Pharmaceuticals is 001-38223.
What is the primary business of Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals, Inc. is classified under the Standard Industrial Classification code 2834, which corresponds to 'Pharmaceutical Preparations'.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 26, 2025 regarding RHYTHM PHARMACEUTICALS, INC. (RYTM).